Kurs kaydını izlemek için tıklayınız.

• 6. Modül Programı
• Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
• Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
• AIEOP-BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia
• Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
• European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia
• Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
• 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
• Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
• Prevention and Treatment of Cancer-Related Infections
• Inotuzumab Ozogamicin Versus Standard of Care in Relapsed or Refractory Acute Lymphoblastic Leukemia: Final Report and Long-Term Survival Follow-Up From the Randomized, Phase 3 INO-VATE Study
• Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms
• Risk Stratification for Invasive Fungal Infections in Patients with Hematological Malignancies: SEIFEM recommendations
• Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues
• A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia
• The acute lymphoblastic leukemia of Down Syndrome e Genetics and pathogenesis
• Clinical and biological aspects of myeloid leukemia in Down syndrome
• Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
• How I treat relapsed acute lymphoblastic leukemia in the pediatric population
• Cancer Stem Cells: Basic Concepts and Therapeutic Implications
• Recommendations of the National Comprehensive Cancer Network® (NCCN®) Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis*
• Optimal Management of Neutropenic Fever in Patients With Cancer
• How I Treat Febrile Neutropenia
• Clonal evolution of acute myeloid leukemia from diagnosis to relapse
• A narrative review of central nervous system involvement in acute leukemias
• Pediatric acute lymphoblastic leukemia
• Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
• Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy
• Role of allogeneic haematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukaemia in the era of immunotherapy
• Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
• SOHO State of the Art Updates & Next Questions: Intensive and Non-Intensive Approaches for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia